WPD Pharmaceuticals WPDPF Stock
WPD Pharmaceuticals Price Chart
WPD Pharmaceuticals WPDPF Financial and Trading Overview
| WPD Pharmaceuticals stock price | 0.0000 USD |
| Previous Close | 1.0E-6 USD |
| Open | 1.0E-6 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 1.0E-6 - 1.0E-6 USD |
| 52 Week Range | 1.0E-6 - 0.03 USD |
| Volume | 200 USD |
| Avg. Volume | 0 USD |
| Market Cap | 18.94K USD |
| Beta (5Y Monthly) | 1.032459 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
WPDPF Valuation Measures
| Enterprise Value | -331283 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.055 |
Trading Information
WPD Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.032459 |
| 52-Week Change | -99.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.03 USD |
| 52 Week Low | 1.0E-6 USD |
| 50-Day Moving Average | 0.0002 USD |
| 200-Day Moving Average | 0.000282 USD |
WPDPF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 113.44M |
| Float | 69.26M |
| Short Ratio | N/A |
| % Held by Insiders | 39.61% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2020 |
| Most Recent Quarter (mrq) | September 30, 2021 |
| Next Fiscal Year End | December 31, 2021 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -128.88% |
| Return on Equity (ttm) | -2179.77% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -107720 USD |
| EBITDA | -6026973 USD |
| Net Income Avi to Common (ttm) | -4858556 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 637.59K USD |
| Total Cash Per Share (mrq) | 0.006 USD |
| Total Debt (mrq) | 306.19K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.395 |
| Book Value Per Share (mrq) | -0.018 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1161818 USD |
| Levered Free Cash Flow (ttm) | -1860162 USD |
Profile of WPD Pharmaceuticals
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 789 West Pender Street |
| ZIP | V6C 2T7 |
| Phone | N/A |
| Website | https://www.wpdpharmaceuticals.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 19 |
WPD Pharmaceuticals Inc., a biotechnology research and development company, engages in the research and development of medicinal products in the fields of oncology and infectious diseases. It develops WPD101 to treat brain cancers; WPD102 for the treatment of uveal melanoma; Berubicin to treat glioblastoma multiforme; and WP1066 for the treatment of glioblastoma and melanoma brain metastases. The company is also developing WP1220 for the treatment of cutaneous T-cell lymphoma; WPD103, a radiopharmaceutical based on the expression of tumor-specific receptors, such as IL-13RA2 and EphA2; and Annamycin to treat solid tumors metastasis to lungs. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada.
Q&A For WPD Pharmaceuticals Stock
What is a current WPDPF stock price?
WPD Pharmaceuticals WPDPF stock price today per share is 0.0000 USD.
How to purchase WPD Pharmaceuticals stock?
You can buy WPDPF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for WPD Pharmaceuticals?
The stock symbol or ticker of WPD Pharmaceuticals is WPDPF.
Which industry does the WPD Pharmaceuticals company belong to?
The WPD Pharmaceuticals industry is Biotechnology.
How many shares does WPD Pharmaceuticals have in circulation?
The max supply of WPD Pharmaceuticals shares is 0.
What is WPD Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
WPD Pharmaceuticals PE Ratio is now.
What was WPD Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
WPD Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the WPD Pharmaceuticals company belong to?
The WPD Pharmaceuticals sector is Healthcare.